Learn how chemists have invented a new technology to solve the shortage of GLP-1 medications by improving drug delivery.

I n addition to their origins as treatment for type 2 diabetes, GLP-1 receptor agonists like Ozempic and Wegovy are often ...

With a FDA deadline set for March 26 to stop compounding versions of Zepbound, followed by restrictions on compounded Ozempic ...

Amy Schumer’s experience with Mounjaro has been vastly different from when she tried an alternative weight-loss medication ...

Amy Schumer recently took to her Instagram handle to share her experience with Midi Health. The 43-year-old actress-comedian ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

First, Novo Nordisk is expanding its program to sell Wegovy GLP-1 weight loss drugs at discounted prices. Second, Novo is ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Wegovy is also available through NovoCare Pharmacy, which directly ship all dose strengths at a cost of $499 per month for ...

Ozempic is not a high-risk medication for most people. It's contraindicated for those who may be sensitive to its ingredients or have a history of thyroid cancer. Along with Wegovy, Ozempic is ...

Medications like Ozempic and Mounjaro work by mimicking naturally occurring hormones in the body, such as glucagon-like ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...